Scientists are reporting the safety and feasibility of a new acute and chronic spinal cord injury treatment platform. Their study demonstrates that administering adult autologous bone marrow derived stem cells via multiple routes is feasible, safe, and most importantly, improves the quality of life for both acute and chronic spinal cord injury patients.